Patents by Inventor Jonathan D. Finn

Jonathan D. Finn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230203480
    Abstract: The invention provides lipid nanoparticle-based compositions and methods useful for delivery of CRISPR/Cas gene editing components.
    Type: Application
    Filed: August 29, 2022
    Publication date: June 29, 2023
    Inventors: David V. Morrissey, Mihir Chandrakant Patel, Jonathan D. Finn, Amy Madison Rhoden Smith, Lucinda J. Shaw, Christian Dombrowksi, Ruchi Rudraprasad Shah
  • Publication number: 20190136231
    Abstract: The invention provides lipid nanoparticle-based compositions and methods useful for delivery of CRISPR/Cas gene editing components.
    Type: Application
    Filed: March 30, 2017
    Publication date: May 9, 2019
    Inventors: David V. MORRISSEY, Mihir Chandrakant PATEL, Jonathan D. FINN, Amy Madison Rhoden SMITH, Lucinda J. SHAW, Christian DOMBROWSKI, Ruchi Rudraprasad SHAH
  • Patent number: 9943574
    Abstract: The invention provides a combination of a source of a CD39 and of a source of a CD73.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: April 17, 2018
    Assignee: Arthrogen B.V.
    Inventor: Jonathan D. Finn
  • Publication number: 20170304466
    Abstract: The invention relates to the field of andeno-associated virus (AAV) based gene therapy, in particular to the use of a combination of recombinant AAV-transgene vectors with an immunosuppressant and/or empty-AAV capsids. The invention further provides a composition and a kit of parts based on this combination.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Jonathan D. FINN, Margarita Jacoba Bernadetta Maria VERVOORDELDONK, Paul-Peter TAK
  • Publication number: 20150190481
    Abstract: The invention provides a combination of a source of a CD39 and of a source of a CD73.
    Type: Application
    Filed: June 26, 2013
    Publication date: July 9, 2015
    Applicant: Arthrogen B.V.
    Inventor: Jonathan D. Finn